Anticoagulants and Immunosuppressives in Behçet’s Syndrome
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis
By Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert
• Context: Behçet’s syndrome is a systemic vasculitis often complicated by venous or arterial thrombosis, yet the optimal role of anticoagulation remains uncertain.
• Study: Across 20 studies (315 patients with disaggregated data), this meta-analysis compared relapse rates under immunosuppressives, anticoagulants, or both.
• Findings: Combination therapy markedly reduced thrombosis relapse (17.7%) versus immunosuppressives alone (43.7%) or anticoagulants alone (54.9%), supporting a dual-modality approach for vascular Behçet’s.”
Title: Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis
Authors: Arisa Chuklin, Thita Chiasakul, Noppacharn Uaprasert
Read the article here.
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025